Efficacy and Tolerability of the Association of Sibutramine and Orlistat for Six Months in Overweight and Obese Patients

Table 4

Studies carried out with sibutramine in non-diabetic patients.

$N$	Reference	Duration(weeks)	Dose (mg/day)	Weight loss
112	12	12	10	−4.5 kg
59	13	12	10	−5.1 kg
62	13	12	15	−4.9 kg
107	14	24	10	−6.1%
99	14	24	15	−7.4%
98	14	24	20	−8.8%

$N$ = Number of individuals treated with sibutramine.